Both SEA-MORE-YIELD projects (2014–2018) apply marine biotechnology to reduce pod shatter in bio-oil producing crops, forming the company's entire H2020 portfolio.
BRANDON PRODUCTS LTD
Irish biotech SME applying marine-derived solutions to reduce pod shatter and improve yield in bio-oil producing oilseed crops.
Their core work
Brandon Products is an Irish biotech SME focused on applying marine-derived biological solutions to improve crop performance in bio-oil production. Their core work centers on reducing pod shatter — the premature seed dispersal that causes significant yield loss in oilseed crops like rapeseed — using blue biotechnology approaches derived from marine sources. They successfully progressed a single technology from feasibility (SME Phase 1) through full development and demonstration (SME Phase 2), indicating a focused, product-oriented company rather than a broad research group. Their work sits at the intersection of marine biotechnology and agricultural productivity, with relevance to the bioenergy and vegetable oil supply chains.
What they specialise in
SEA-More-Yield Phase 1 and Phase 2 are both explicitly focused on pod shatter as the target problem in bio-oil crop production.
Brandon successfully converted a Phase 1 feasibility study (€50k, 2014) into a Phase 2 development grant (€828k, 2016), demonstrating competence in structured EU innovation pathways.
The 'blue biotechnology' framing of SEA-More-Yield implies use of marine organisms or compounds as the active ingredient in an agricultural application.
How they've shifted over time
Brandon's H2020 history is entirely built around a single technology — the Sea-More-Yield platform — pursued in two sequential phases between 2014 and 2018. There is no observable keyword or thematic shift between projects because both represent the same innovation at different stages of development, not a broadening or pivot of focus. This means no evolution in research direction can be detected; what can be said is that their Phase 1-to-Phase 2 progression reflects growing maturity and commercial readiness of the same core technology.
Brandon appears to have been building toward commercializing a single marine biotech product for oilseed agriculture; whether they have continued beyond 2018 or successfully brought the product to market is not visible from H2020 data alone.
How they like to work
Brandon consistently acted as project coordinator across both H2020 projects, indicating comfort with project leadership and EU grant management. However, their consortium footprint is minimal — just one unique partner across two projects and a single country of collaboration — suggesting they operate as a focused, largely self-contained unit rather than a network builder. Anyone looking to partner with them should expect a company that leads on its own technology rather than one experienced in large multi-partner consortia.
Brandon's collaboration network is extremely narrow — one unique partner in one country across their entire H2020 history. This is consistent with an SME advancing a proprietary product through the Horizon SME Instrument, which is designed for single-company-led innovation rather than broad consortium work.
What sets them apart
Brandon occupies a rare niche: applying marine biology to solve a specific agronomic problem — pod shatter — that costs the oilseed and biofuel industries measurable yield losses every harvest season. Very few organizations combine marine biotechnology with this particular crop performance challenge, making them a distinctive potential partner for agrifood or bioenergy actors seeking unconventional biological solutions. Their full Phase 1 → Phase 2 track record demonstrates they can execute under EU funding structures, not just propose ideas.
Highlights from their portfolio
- SEA-More-YieldSecured €828,625 in SME Phase 2 funding — the more competitive and larger of the two Horizon SME Instrument phases — validating the commercial potential of their marine biotech approach to oilseed crop improvement.
- SEA-MORE-YIELDThe Phase 1 feasibility project (€50k, 2014) launched the company's EU innovation pathway and was the stepping stone that unlocked the larger Phase 2 development grant two years later.